InsidersTradesSigma
Track the Cohance Lifesciences Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Cohance Lifesciences Limited has published 6 public disclosures. Market capitalisation: €162.6bn. The latest transaction was filed on 19 September 2025 (Sale). Among the most active insiders: Jusmiral Holdings Limited. Every trade is free.
Analysts rate Cohance Lifesciences Limited Hold (neutral), based on 9 analysts. Average price target: ₹514.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Cohance Lifesciences Limited 是一家专注于医疗保健和制药领域的公司。该公司在 XBOM 上市。